STAMFORD, CT--(BUSINESS WIRE)--Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP). The full-day meeting on October 7 was part of the FDA's customary review of PMI's request to continue marketing versions of its IQOS heated tobac.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In the last decade, Philip Morris International (NYSE: PM) has returned a notable $74 billion back to its shareholders via dividends and buybacks. This shareholder-focused approach has delivered exceptional results in 2025, with the stock posting an impressive 30% year-to-date return, significantly outperforming the broader market despite recent volatility and establishing PM as one of the year's standout consumer staples performers.

Philip Morris delivered strong Q2 2024 results, driven by record revenues, robust smoke-free product growth, and expanding operating margins. Despite operational momentum, PM's current valuation appears stretched versus peers MO and BTI, making its risk/reward less attractive at current prices. Remain neutral on PM, expecting a retracement to around $147 before turning bullish again, which would offer a more compelling entry and a 4% dividend yield.

Philip Morris International (PM) remains a strong buy after a recent sell-off, with long-term growth prospects outweighing short-term concerns. PM's dominant positions in smokeless (Zyn) and heated tobacco (IQOS) markets, plus successful acquisitions, support robust earnings growth projections. Despite slower Zyn growth and regulatory headwinds, PM's innovation and market share gains in key segments reinforce its leadership and undervaluation.

STAMFORD, Conn.--(BUSINESS WIRE)--A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes and growing worries about how public health decisions are made. The survey found that 78% of respondents agree that adult smokers in all countries should have access to better alternatives to continued smoking. Approximately three-quarters (74%) believe that encouraging people who.

PM has raised its quarterly dividend by 8.9%, underscoring growth through smoke-free products, cost savings and strong brands.

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Philip Morris International Inc. (PMI) (NYSE: PM) has increased the company's regular quarterly dividend by 8.9% to an annualized rate of $5.88 per share. The new quarterly dividend of $1.47 per share, up from $1.35 per share, is payable on October 20, 2025, to shareholders of record as of October 3, 2025. The ex-dividend date is October 3, 2025. PMI has increased its annual dividend every year since becoming a public com.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Philip Morris has shown strong stock performance, up more than 30% over the last year. The company boasts a long history of growing dividends, with expectations for another increase in September supported by improving fundamentals and a lower payout ratio. Key growth drivers include the fruits of the successful Swedish Match acquisition, including ZYN, though innovation, regulation, and currency remain notable risks.